Arbutus Biopharma Corp Financial Flexibility Index
Arbutus Biopharma Corp financial flexibility index. Arbutus Biopharma Corp (ABUS) has a Financial Flexibility Index of 0.00x as of June 2026. Free cash flow of $-65.69K (operating CF $-6.02 Million minus capex $5.95 Million) represents 0% of total liabilities ($15.29 Million). See free cash flow generation of Arbutus Biopharma Corp to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Arbutus Biopharma Corp (1998–2025)
Financial flexibility index of Arbutus Biopharma Corp from 1998 to 2025. Historical Financial Flexibility Index trend for Arbutus Biopharma Corp across 28 annual periods. Check ABUS operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Arbutus Biopharma Corp Financial Flexibility Index by Year (1998–2025)
Arbutus Biopharma Corp financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Arbutus Biopharma Corp. For the full cash flow conversion analysis, see how efficiently does Arbutus Biopharma Corp generate cash.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.20x | $-39.64 Million | $-39.64 Million | $18.04 Million | ▼ -16.7% |
| 2024 | -1.88x | $-64.67 Million | $-64.85 Million | $34.34 Million | ▲ +14.9% |
| 2023 | -2.21x | $-84.93 Million | $-85.94 Million | $38.38 Million | ▼ -271.9% |
| 2022 | -0.59x | $-34.84 Million | $-35.36 Million | $58.57 Million | ▲ +68.8% |
| 2021 | -1.90x | $-66.72 Million | $-67.53 Million | $35.05 Million | ▼ -30.5% |
| 2020 | -1.46x | $-51.21 Million | $-51.44 Million | $35.11 Million | ▲ +32.1% |
| 2019 | -2.15x | $-70.42 Million | $-71.01 Million | $32.79 Million | ▲ +11.0% |
| 2018 | -2.41x | $-66.76 Million | $-67.90 Million | $27.67 Million | ▼ -219.3% |
| 2017 | -0.76x | $-41.34 Million | $-48.60 Million | $54.70 Million | ▼ -2.2% |
| 2016 | -0.74x | $-53.89 Million | $-57.88 Million | $72.90 Million | ▼ -131.8% |
| 2015 | -0.32x | $-52.50 Million | $-54.78 Million | $164.61 Million | ▲ +15.3% |
| 2014 | -0.38x | $-11.37 Million | $-12.42 Million | $30.20 Million | ▲ +21.6% |
| 2013 | -0.48x | $-6.01 Million | $-6.74 Million | $12.52 Million | ▼ -116.8% |
| 2012 | 2.85x | $33.29 Million | $33.27 Million | $11.68 Million | ▲ +424.6% |
| 2011 | -0.88x | $-7.46 Million | $-7.52 Million | $8.50 Million | ▲ +13.3% |
| 2010 | -1.01x | $-10.42 Million | $-11.25 Million | $10.29 Million | ▼ -82.3% |
| 2009 | -0.56x | $-3.62 Million | $-5.24 Million | $6.51 Million | ▲ +70.1% |
| 2008 | -1.85x | $-7.52 Million | $-8.48 Million | $4.05 Million | ▼ -784.4% |
| 2007 | -0.21x | $-1.36 Million | $-2.72 Million | $6.46 Million | ▲ +51.2% |
| 2006 | -0.43x | $-2.53 Million | $-2.62 Million | $5.88 Million | ▼ -9.5% |
| 2005 | -0.39x | $-14.53 Million | $-14.57 Million | $36.99 Million | ▼ -615.2% |
| 2004 | -0.05x | $-2.83 Million | $-9.98 Million | $51.60 Million | ▲ +98.5% |
| 2003 | -3.56x | $-26.18 Million | $-26.96 Million | $7.35 Million | ▼ -73.0% |
| 2002 | -2.06x | $-16.21 Million | $-18.16 Million | $7.87 Million | ▼ -39.1% |
| 2001 | -1.48x | $-9.06 Million | $-10.00 Million | $6.12 Million | ▲ +54.7% |
| 2000 | -3.27x | $-8.15 Million | $-8.35 Million | $2.49 Million | ▲ +4.0% |
| 1999 | -3.40x | $-6.54 Million | $-6.84 Million | $1.92 Million | ▼ -6.6% |
| 1998 | -3.19x | $-4.49 Million | $-7.71 Million | $1.40 Million | — |